(Q37474525)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

review article

1 reference

title

Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

0 references

anti-retroviral agent

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Bruce J Brew

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Lucette A Cysique

series ordinal

1

1 reference

20 August 2017

Bruce J Brew

series ordinal

2

1 reference

20 August 2017

9 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

published in

Neuropsychology Review

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

169-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11065-009-9092-3

27 January 2020

exact match

0 references

cites work

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

12 December 2020

Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals

1 reference

12 December 2020

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir

1 reference

12 December 2020

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

1 reference

12 December 2020

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients

1 reference

12 December 2020

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

1 reference

12 December 2020

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

12 December 2020

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

1 reference

12 December 2020

Preventing HIV antiretroviral resistance through better monitoring of treatment adherence

1 reference

12 December 2020

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

1 reference

12 December 2020

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

1 reference

12 December 2020

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

1 reference

12 December 2020

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

1 reference

12 December 2020

Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management?

1 reference

12 December 2020

Response to systemic HIV viral load suppression correlates with psychomotor speed performance.

1 reference

12 December 2020

Adherence-resistance relationships to combination HIV antiretroviral therapy

1 reference

12 December 2020

Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples

1 reference

12 December 2020

Long-term effects of high-dose zidovudine treatment on neuropsychological performance in mildly symptomatic HIV-positive patients: results of a randomized, double-blind, placebo-controlled investigation

1 reference

12 December 2020

Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome

1 reference

12 December 2020

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study

1 reference

12 December 2020

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

1 reference

12 December 2020

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

1 reference

12 December 2020

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

12 December 2020

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

12 December 2020

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

1 reference

12 December 2020

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

12 December 2020

Markers of AIDS dementia complex: the role of cerebrospinal fluid assays

1 reference

12 December 2020

Antiretroviral drugs and the central nervous system.

1 reference

12 December 2020

Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy

1 reference

12 December 2020

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

1 reference

12 December 2020

Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimens.

1 reference

12 December 2020

CD4+ count-guided interruption of antiretroviral treatment

1 reference

12 December 2020

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Neurodegeneration and ageing in the HAART era.

1 reference

12 December 2020

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

1 reference

12 December 2020

Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

1 reference

12 December 2020

Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

1 reference

12 December 2020

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

1 reference

12 December 2020

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

12 December 2020

Longitudinal Improvement in Psychomotor Processing Speed Is Associated With Potent Combination Antiretroviral Therapy in HIV-1 Infection

1 reference

12 December 2020

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region

1 reference

12 December 2020

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

1 reference

12 December 2020

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

12 December 2020

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

12 December 2020

Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex

1 reference

12 December 2020

Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.

1 reference

12 December 2020

N-acetylaspartate--a marker of neuronal integrity

1 reference

12 December 2020

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

1 reference

12 December 2020

The blood brain barrier in HIV infection

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Only temporary improvement in impaired neuropsychological function in AIDS patients treated with zidovudine

1 reference

12 December 2020

The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function

1 reference

12 December 2020

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort

1 reference

12 December 2020

HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease

1 reference

12 December 2020

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

1 reference

12 December 2020

HIV infection and dementia in older adults

1 reference

12 December 2020

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.

1 reference

12 December 2020

Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment

1 reference

12 December 2020

Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090.

1 reference

12 December 2020

Adherence to HAART Regimens

1 reference

12 December 2020

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial

1 reference

12 December 2020

Practice and drop-out effects during a 17-year longitudinal study of cognitive aging.

1 reference

12 December 2020

Therapeutic effects of nucleoside analogues on psychomotor slowing in HIV infection

1 reference

12 December 2020

Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort.

1 reference

12 December 2020

Lost in translation: again, another failed neuroprotection trial.

1 reference

12 December 2020

Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins

1 reference

12 December 2020

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

1 reference

12 December 2020

Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center

1 reference

12 December 2020

Sample size re-estimation for adaptive sequential design in clinical trials

1 reference

12 December 2020

Mitochondrial toxicity of nucleoside analogues: mechanism, monitoring and management

1 reference

12 December 2020

Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection

1 reference

12 December 2020

Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS.

1 reference

12 December 2020

Development of a statistical approach to classifying treatment response in individual children with ADHD.

1 reference

12 December 2020

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

1 reference

12 December 2020

10.1007/S11065-009-9092-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19424802%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference